Stay updated on VX-809 and VX-770 in CF Clinical Trial
Sign up to get notified when there's something new on the VX-809 and VX-770 in CF Clinical Trial page.

Latest updates to the VX-809 and VX-770 in CF Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- Revision: v3.4.2 added; previous v3.4.1 notice removed.SummaryDifference0.3%

- Check20 days agoChange DetectedAdded a government funding notice at the top of the page and updated the site version to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a glossary toggle and updated footer text capitalization (Last Update Submitted that Met QC Criteria; No FEAR Act Data). Revision tag updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 appears on the page in place of v3.3.3, reflecting a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedLocations section updated with additional sites across many US states and international locations (including Rhone and Thuringia) and several sites removed. The HHS Vulnerability Disclosure entry was removed.SummaryDifference2%

- Check85 days agoChange DetectedThe page footer now shows a new revision number: v3.3.2, replacing the previous v3.3.1.SummaryDifference0.0%

Stay in the know with updates to VX-809 and VX-770 in CF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-809 and VX-770 in CF Clinical Trial page.